May & Baker Nigeria Plc stands as one of the oldest and most established pharmaceutical manufacturers in Nigeria. Known for producing essential medications across pain management, anti-infectives, cardiovascular care, and anti-diabetics, the company supplies products to hospitals and community pharmacies nationwide.
To protect public safety and prevent counterfeiting, every legitimate product released by May & Baker carries a specific registration code issued by the National Agency for Food and Drug Administration and Control (NAFDAC).
This comprehensive catalog lists key May & Baker pharmaceutical formulations alongside their official NAFDAC registration numbers, active ingredients, dosage forms, and primary medical uses.
📋 In This Article
Analgesics and Pain Relief Products
Antimalarial Formulations
Antibacterials and Anti-infective Medications
Cardiovascular and Metabolic Health Care
Gastrointestinal and Anthelmintic Treatments
Respiratory and Allergy Relief Solutions
Antiretroviral and Central Nervous System Drugs
How To Confirm May & Baker Products At The Pharmacy
Frequently Asked Questions
Analgesics and Pain Relief Products
Pain management and fever reduction represent core product categories for May & Baker. Their OTC pain relievers are among the most widely distributed analgesics in Nigerian healthcare.
M & B Paracetamol Tablet
Active Ingredient: Paracetamol 500mg
Dosage Form: Oral Tablet
NAFDAC Registration Number: 04-0633
Primary Indications: Relief of mild-to-moderate pain, headache, fever, and muscle aches.
M & B Paracetamol Syrup
Active Ingredient: Paracetamol 120mg / 5mL
Dosage Form: Oral Suspension / Syrup
NAFDAC Registration Number: 04-0247
Primary Indications: Pediatric fever management and pain relief in infants and children.
Easadol Caplet
Active Ingredient: Paracetamol 500mg
Dosage Form: Caplet
NAFDAC Registration Number: 04-8592
Primary Indications: Rapid relief from general pain, body soreness, and febrile conditions.
Easadol Plus
Active Ingredients: Ibuprofen 200mg + Paracetamol 325mg + Caffeine 30mg
Dosage Form: Caplet
NAFDAC Registration Number: A11-0118
Primary Indications: Enhanced relief for severe body pains, persistent headaches, and acute inflammation.
M & B Ibuprofen Liquid
Active Ingredient: Ibuprofen 100mg / 5mL
Dosage Form: Oral Suspension
NAFDAC Registration Number: A11-0117
Primary Indications: Anti-inflammatory, analgesic, and antipyretic relief for swelling, fever, and pain.
Ketovail
Active Ingredient: Ketoprofen 200mg
Dosage Form: Capsule
NAFDAC Registration Number: A4-0839
Primary Indications: Non-steroidal anti-inflammatory treatment for joint pain, arthritis, and severe muscular pain.
Antimalarial Formulations
Malaria treatment remains a critical public health priority in West Africa. May & Baker provides artemisinin-based combination therapies (ACTs) formulated for treatment protocols.
Artelum Tablet
Active Ingredients: Artemether 40mg + Lumefantrine 240mg
Dosage Form: Oral Tablet
NAFDAC Registration Number: A4-0850
Primary Indications: First-line treatment of uncomplicated Plasmodium falciparum malaria.
Malact Tablet
Active Ingredients: Dihydroartemisinin 40mg + Piperaquine 320mg
Dosage Form: Tablet
NAFDAC Registration Number: B4-80004
Primary Indications: Artemisinin-based combination therapy for acute malaria infections.
Antibacterials and Anti-infective Medications
May & Baker supplies broad-spectrum antibiotics to treat bacterial, fungal, and protozoal infections.
M & B Cipro
Active Ingredient: Ciprofloxacin 500mg
Dosage Form: Caplet / Tablet
NAFDAC Registration Number: 04-8805
Primary Indications: Broad-spectrum treatment for urinary tract infections, respiratory infections, and systemic bacterial conditions.
Loxaclav 625 Tablet
Active Ingredients: Amoxicillin 500mg + Clavulanic Acid 125mg
Dosage Form: Tablet
NAFDAC Registration Number: 04-7942
Primary Indications: Beta-lactamase resistant penicillin antibiotic for ENT infections, skin infections, and bronchitis.
Loxaclav Dry Powder Suspension
Active Ingredients: Amoxicillin 200mg + Clavulanic Acid 28.5mg / 5mL
Dosage Form: Pediatric Oral Suspension
NAFDAC Registration Number: 04-7842
Primary Indications: Pediatric bacterial infections covering upper respiratory tract and ear infections.
Levotil
Active Ingredient: Levofloxacin 500mg
Dosage Form: Caplet
NAFDAC Registration Number: 04-9438
Primary Indications: Fluoroquinolone antibiotic for severe respiratory, sinus, and prostate infections.
Loxagyl 200mg Tablet
Active Ingredient: Metronidazole 200mg
Dosage Form: Oral Tablet
NAFDAC Registration Number: 04-0283
Primary Indications: Treatment of anaerobic bacterial infections, amoebiasis, and giardiasis.
Loxagyl 400mg Tablet
Active Ingredient: Metronidazole 400mg
Dosage Form: Oral Tablet
NAFDAC Registration Number: 04-5566
Primary Indications: High-strength anti-protozoal and anti-anaerobic treatment.
Loxaprim Tablet
Active Ingredients: Sulfamethoxazole 400mg + Trimethoprim 80mg (Co-trimoxazole 480mg)
Dosage Form: Tablet
NAFDAC Registration Number: 04-5567
Primary Indications: Treatment of susceptible bacterial infections, gastrointestinal infections, and chest infections.
Oxavid
Active Ingredient: Ofloxacin 200mg
Dosage Form: Caplet
NAFDAC Registration Number: 04-8089
Primary Indications: Quinolone antibiotic for urinary tract infections and pelvic inflammatory conditions.
Furoxetil
Active Ingredient: Cefuroxime Axetil 500mg
Dosage Form: Tablet
NAFDAC Registration Number: A4-8175
Primary Indications: Second-generation cephalosporin for throat, ear, and soft tissue infections.
Cepharox Injection
Active Ingredient: Ceftriaxone 1g
Dosage Form: Powder for Injection (Vial)
NAFDAC Registration Number: 04-7900
Primary Indications: Injectable antibiotic for severe hospital-acquired bacterial infections, sepsis, and meningitis.
Cardiovascular and Metabolic Health Care
May & Baker supplies key prescription medicines for managing high blood pressure and type 2 diabetes mellitus.
Cardovasc Retard
Active Ingredient: Nifedipine 20mg
Dosage Form: Sustained-Release Tablet
NAFDAC Registration Number: 04-7943
Primary Indications: Calcium channel blocker for managing hypertension and chronic stable angina.
Cardovasc XL
Active Ingredient: Nifedipine 30mg
Dosage Form: Extended-Release Tablet
NAFDAC Registration Number: 04-7946
Primary Indications: Long-acting blood pressure control and angina prevention.
Ramitace 5mg
Active Ingredient: Ramipril 5mg
Dosage Form: Tablet
NAFDAC Registration Number: 04-9437
Primary Indications: ACE inhibitor for blood pressure reduction, post-myocardial infarction care, and kidney protection.
Ramitace 10mg
Active Ingredient: Ramipril 10mg
Dosage Form: Capsule
NAFDAC Registration Number: A4-4333
Primary Indications: High-strength ACE inhibitor therapy for hypertension and cardiovascular risk reduction.
Thiapril
Active Ingredients: Ramipril 5mg + Hydrochlorothiazide 12.5mg
Dosage Form: Tablet
NAFDAC Registration Number: 04-7838
Primary Indications: Combination antihypertensive therapy for resistant high blood pressure.
Diamet
Active Ingredient: Metformin Hydrochloride 500mg
Dosage Form: Tablet
NAFDAC Registration Number: 04-7945
Primary Indications: First-line biguanide oral hypoglycemic agent for type 2 diabetes management.
Diatab
Active Ingredient: Glibenclamide 5mg
Dosage Form: Tablet
NAFDAC Registration Number: 04-7837
Primary Indications: Sulfonylurea antidiabetic drug used to lower blood sugar in type 2 diabetes.
Mepiryl 2mg
Active Ingredient: Glimepiride 2mg
Dosage Form: Tablet
NAFDAC Registration Number: 04-9605
Primary Indications: Second-generation sulfonylurea for glycemic control.
Co-Mepiryl
Active Ingredients: Metformin 500mg + Glimepiride 2mg
Dosage Form: Tablet
NAFDAC Registration Number: A4-2825
Primary Indications: Combination therapy for dual blood glucose management in type 2 diabetes.
Gastrointestinal and Anthelmintic Treatments
Treatments for stomach acid management, gut infections, and intestinal parasites form an important segment of the May & Baker pharmaceutical range.
Rabezole
Active Ingredient: Rabeprazole Sodium 20mg
Dosage Form: Gastro-resistant Tablet
NAFDAC Registration Number: B4-9669
Primary Indications: Proton pump inhibitor for peptic ulcer disease, acid reflux, and GERD.
Secwid
Active Ingredient: Secnidazole 500mg
Dosage Form: Caplet
NAFDAC Registration Number: 04-7821
Primary Indications: Single-dose or short-course nitroimidazole for intestinal amoebiasis, giardiasis, and bacterial vaginosis.
Respiratory and Allergy Relief Solutions
May & Baker manufactures pediatric syrups and oral cold remedies designed to relieve allergic symptoms, coughs, and nasal congestion.
Rophegan Syrup
Active Ingredient: Promethazine Hydrochloride 5mg / 5mL
Dosage Form: Oral Liquid Syrup
NAFDAC Registration Number: 04-0290
Primary Indications: Antihistamine for allergic conditions, motion sickness, and mild sedation.
Mobitin Liquid
Active Ingredient: Chlorpheniramine Maleate 2mg / 5mL
Dosage Form: Syrup
NAFDAC Registration Number: A11-0115
Primary Indications: Relief from sneezing, runny nose, itching, and general allergic rhinitis.
Maysedyl All-Day
Active Ingredients: Paracetamol 325mg + Phenylephrine 5mg + Dextromethorphan 10mg
Dosage Form: Capsule
NAFDAC Registration Number: B4-5980
Primary Indications: Multi-symptom cold and flu relief covering nasal congestion, cough, and mild fever.
Antiretroviral and Central Nervous System Drugs
May & Baker also produces regulated therapeutics for specialized treatment regimens under institutional healthcare programs.
M & B Efavirenz
Active Ingredient: Efavirenz 600mg
Dosage Form: Tablet
NAFDAC Registration Number: A4-2582
Primary Indications: Non-nucleoside reverse transcriptase inhibitor (NNRTI) for HIV-1 management.
M & B Lamivudine & Zidovudine
Active Ingredients: Lamivudine 150mg + Zidovudine 300mg
Dosage Form: Tablet
NAFDAC Registration Number: A4-2583
Primary Indications: Dual nucleoside analog combination therapy for antiretroviral treatment.
Bromatan 1.5mg
Active Ingredient: Bromazepam 1.5mg
Dosage Form: Tablet
NAFDAC Registration Number: A4-2663
Primary Indications: Short-term management of severe anxiety and tension disorders.
How To Confirm May & Baker Products At The Pharmacy
Counterfeiters often target trusted household names. To verify that a May & Baker medicine is authentic:
Check the Prefix Format: Locally manufactured May & Baker products feature numbers starting with 04- or B4-. Imported formulations or active pharmaceutical ingredients generally begin with A4- or A11-.
Match the Product Identity: Ensure the printed NAFDAC number matches the exact product name and strength on the box. If a code listed for a paracetamol tablet appears on an antibiotic syrup, the packaging is cloned and fraudulent.
Inspect Physical Packaging: Authentic May & Baker cartons display crisp printing, clear manufacturing and expiration dates, batch numbers, and intact security seals.
Use Digital Verification Tools: Search the NAFDAC Greenbook database or use Mobile Authentication Service (MAS) scratch codes where present to confirm product authenticity before consumption.
Frequently Asked Questions
1. Where are May & Baker products manufactured?
May & Baker operates major pharmaceutical manufacturing facilities in Ikeja, Lagos State, and Ota, Ogun State, producing liquids, tablets, and oral suspensions under Good Manufacturing Practice (GMP) standards.
2. How can I tell if a May & Baker product is locally made or imported?
Look at the prefix of the NAFDAC number. Numbers starting with 04- represent locally formulated products made within Nigerian production plants. Prefixes starting with A4- or A11- indicate imported products or imported finished drug formulations registered by the company.
3. What should I do if a May & Baker drug lacks a NAFDAC number?
Do not buy or use any pharmaceutical product that lacks a visible NAFDAC registration code. Report suspicious or unlabelled products to NAFDAC authorities or directly to May & Baker's customer care channels.
🛡️ Verify Registration Codes and Products Online
Cross-check NAFDAC registration numbers, active chemical ingredients, and safety notices on official regulatory channels before administering prescription or over-the-counter medications.